Our Manufacturing
Celon works in niche therapy segments – a space that demands advanced manufacturing capabilities. To that end, we equip ourselves with the best-in-class technology and the best in segment practices. We adopt an approach that keeps the end customer at the centre.
Our manufacturing infrastructure enables us to comply with Indian and international regulatory requirements.
Our expertise in novel technology platforms enables in-house development of potential molecules in our focus therapy areas.
Robust Pipeline of TKIs (Tyrosine Kinase Inhibitors)
With an established product portfolio in ROW markets like LATAM, Africa, SEA, CIS etc, Celon has expertise in manufacturing formulations across a wide spectrum. We today manufacture liquid, dry powder, lipid, liposomal, polymer based microspheres and lyophilised formulations. And, we make them available in ampoules, vials and a range of oral solid dosages.
Salient features of our QMS
- Integrated approach towards quality control, quality assurance, production and regulatory affairs.
- State-of-the-art analytical instrumentation, quality assurance and quality control systems at each manufacturing step to monitor product quality.
- Continuous improvement of the procedures, processes, technologies and infrastructure assures the quality of our products.
- End-to-End process validation.
- Comprehensive analytical method validation.
- Absolute adherence to cGMPs and ICH guidelines.
- Well-established change control process.
- Quality audits and continuous training at all levels.
Facility approvals from global regulatory authorities
| DIGEMID, Peru | DDA, Nepal |
| FDA, Phillipines | ROSZDRAVNADZOR, Russia |
| DRA, Kenya | RRFA, Ivory Cost |
| NDA, Uganda |
- Zero effluent discharge systems
- HVAC for sanitized, pollution-free conditions
- Regular training
Salient features of our QMS
- Integrated approach towards Quality Control, Quality Assurance, Production and Regulatory Affairs
- State-of-the-art analytical instrumentation, quality assurance and quality control systems at each manufacturing step to monitor product quality.
- Continuous improvement of the procedures, processes, technologies and infrastructure assures the quality of our products.
- End-to-End process validation.
- Comprehensive analytical method validation
- Absolute adherence to cGMPs and ICH guidelines.
- Well-established change control process.
- Quality audits and continuous training at all levels.
| INVIMA, Columbia | NAFDAC, Nigeria | NDA, Uganda |
| FDB, Ghana | DRAP, Pakistan | MPH, Yemen |
| PPB, Kenya | NMPB, Sudan | MCAZ, Zimbabwe |
| NMRC, Namibia | MOH, Syria | MOH, Libya |
| MOH, Nepal | MOH, Tajikistan | MMOH, Iran |
CANCER AWARNESS PROGRAMS
CANCER DETECTION CAMPS
